Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence of Secondary Cardiac Damage in Rheumatic Fever Patients and Adherence to Penicillin Secondary Prophylaxis

NCT03183180 is registered in ClinicalTrials.gov with Assuta Hospital Systems as lead sponsor.

NCT NCT03183180
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03183180 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence of Secondary Cardiac Damage in Rheumatic Fever Patients and Adherence to Penicillin Secondary Prophylaxis
Lead sponsor
Assuta Hospital Systems
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2017
Completion date
May 31, 2019
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

secondary cardiac damage in rheumatic fever